Agienic has developed novel cuprous-ion based antimicrobial materials technology. These materials can be incorporated in many consumer products to kill microbes such as bacteria and viruses to reduce sickness caused by infection. There are several other industrial uses of Agienic’s technology, particularly in oil & gas wells.
Primary Application Area: Biotech, Pharma
Technology Development Status: Proven Manufacturability
FIGURES OF MERIT
Value Proposition: Agienic’s antimicrobial materials have superior efficacy against a broad range of microbes at a lower cost compared with competing technologies such as silver-based materials. These can be delivered in a wide variety of forms. The key to the success of Agienic’s antimicrobial particles is the surface modification (functionalization) of their surfaces which is carried out. This functionalization can be tailored to make the particles attractive to microbes and compatible with a wide range of materials and products.
Agienic has developed a laboratory-scale manufacturing process which is simple, reliable, environmentally friendly, economically effective and scalable. In addition, Agienic has conducted preliminary toxicology testing to confirm the safety of its products and is pursuing EPA approval to register its products.
Organization Type: Early-stage Startup (Seed)
Showcase Booth #: 30T
GOVT/EXTERNAL FUNDING SOURCES